Limited Liability Partnership registration number SO306857 (Scotland)
LARKHALL SURGERY LLP
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
LARKHALL SURGERY LLP
LIMITED LIABILITY PARTNERSHIP INFORMATION
Designated members
Mr S G M Braidwood
Mr A B Braidwood
Registered number
SO306857
Registered office
C/O AAB
10th Floor
133 Finnieston Street
Glasgow
G3 8HB
Accountants
AAB Business and Tax Advisory LLP
133 Finnieston Street
Glasgow
G3 8HB
LARKHALL SURGERY LLP
CONTENTS
Page
Profit and loss account (Not filed)
1
Balance sheet
2
Notes to the financial statements
3 - 5
LARKHALL SURGERY LLP
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2026
- 1 -
2026
2025
Notes
£
£
Turnover
166,315
166,610
Administrative expenses
(4,592)
(4,102)
Profit for the financial year before members' remuneration and profit shares available for discretionary division among members
161,723
162,508

The profit and loss account has been prepared on the basis that all operations are continuing operations.

LARKHALL SURGERY LLP
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 2 -
2026
2025
Notes
£
£
£
£
Fixed assets
Investment property
3
1,380,000
1,380,000
Current assets
Debtors
4
2,528
925
Cash at bank and in hand
174,471
174,546
176,999
175,471
Creditors: amounts falling due within one year
5
(15,276)
(12,963)
Net current assets
161,723
162,508
Total assets less current liabilities and net assets attributable to members
1,541,723
1,542,508
Represented by:
Loans and other debts due to members within one year
Amounts due in respect of profits
161,723
162,508
Other amounts
1,380,000
1,380,000
1,541,723
1,542,508
TOTAL MEMBERS' INTERESTS
Loans and other debts due to members
1,541,723
1,542,508

For the financial year ended 31 March 2026 the limited liability partnership was entitled to exemption from audit under section 477 of the Companies Act 2006 as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 relating to small limited liability partnerships.

The members acknowledge their responsibilities for complying with the requirements of the Act as applied to limited liability partnerships with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to limited liability partnerships subject to the small limited liability partnerships regime.

The members of the limited liability partnership have elected not to include a copy of the profit and loss account within the financial statements.

The financial statements were approved by the members and authorised for issue on 1 July 2026 and are signed on their behalf by:
01 July 2026
Mr A B Braidwood
Designated member
Limited Liability Partnership registration number SO306857 (Scotland)
LARKHALL SURGERY LLP
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
1
Accounting policies
Limited liability partnership information

Larkhall Surgery LLP is a limited liability partnership incorporated in Scotland. The registered office is C/O AAB, 10th Floor, 133 Finnieston Street, Glasgow, G3 8HB.

 

The limited liability partnership's principal activities are disclosed in the Members' Report.

1.1
Basis of preparation

These financial statements have been prepared in accordance with the Statement of Recommended Practice "Accounting by Limited Liability Partnerships" issued in May 2024, together with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the limited liability partnership. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable.

 

Turnover represents the rent receivable on the investment property when it falls due.

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.3
Investment property

Investment properties are included at fair value with any gains or losses recognised in Statement of comprehensive income.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The LLP only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade debtors and creditors. These are measured at amortised cost and are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

LARKHALL SURGERY LLP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -
Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the limited liability partnership transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the limited liability partnership’s obligations expire or are discharged or cancelled.

2
Employees

The average number of persons (excluding members) employed by the partnership during the year was:

2026
2025
Number
Number
Total
0
0
LARKHALL SURGERY LLP
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 5 -
3
Investment property
2026
£
Fair value
At 1 April 2025 and 31 March 2026
1,380,000

The members are satisfied that the limited liability partnership's investment property is included at fair value.

4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
1,535
-
Other debtors
993
925
2,528
925
5
Creditors: amounts falling due within one year
2026
2025
£
£
Taxation and social security
12,013
10,098
Other creditors
3,263
2,865
15,276
12,963
6
Loans and other debts due to members

Loans and other debts due to members rank equally with debts due to unsecured creditors in the event of a winding up. There is no provision for specific legally enforceable protection afforded to creditors in such an event. There is no restrictions or limitations on the ability of the members to reduce the amount of 'Members' other interests'.

In the event of a winding up the amounts included in "Loans and other debts due to members" will rank equally with unsecured creditors.

2026-03-312025-04-01falsefalse01 July 2026CCH SoftwareCCH Accounts Production 2026.100falseSO3068572025-04-012026-03-31SO306857bus:PartnerLLP12025-04-012026-03-31SO306857bus:PartnerLLP22025-04-012026-03-31SO3068572024-04-012025-03-31SO3068572026-03-31SO306857bus:LimitedLiabilityPartnershipLLP2025-04-012026-03-31SO306857bus:SmallCompaniesRegimeForAccounts2025-04-012026-03-31SO306857bus:FRS1022025-04-012026-03-31SO306857bus:AuditExemptWithAccountantsReport2025-04-012026-03-31SO306857bus:FullAccounts2025-04-012026-03-31xbrli:purexbrli:sharesiso4217:GBP